InTech joins world’s largest diabetes campaign - World Diabetes Day
November 13, 2015
On November 14, 2015, we are joining the world’s largest diabetes campaign - World Diabetes Day - uniting with the global diabetes community to produce a powerful voice for diabetes awareness and advocacy.
According to the World Health Organization, diabetes will be the seventh leading cause of death in 2030. It is a disease that affects the whole family, especially when a child is diagnosed.
Led by the International Diabetes Federation, WDD is a year-long campaign to reflect the realities of dealing with this chronic condition.
Our most important contribution to the campaign is the new open access book titled “Major Topics in Type 1 Diabetes”, edited by Dr. Kenia Nunes and published on November 14, 2015. The book focuses on lesser explored topics regarding the Type 1 diabetes (T1D), subjects that are important from the point of view of future treatments.
“Type 1 diabetes is largely considered an autoimmune disorder and its pathophysiology is still not completely understood,” Dr. Nunes says. “Although therapies ameliorate the manifestations of the disease no cure is currently available.”
“Highlighting less explored topics linked to T1D, but very important and recent knowledge that presage directions for further research, each chapter in this book provides unique information on emergent aspects of T1D written by widely acknowledged experts,” Nunes explains.
Dr. Kenia Pedrosa Nunes is a vascular biologist who studies diseases such as diabetes, hypertension, and especially erectile dysfunction (ED). She received her master’s degree in Molecular and Biochemistry Pharmacology and her Ph.D. in Physiology from the Federal University of Minas Gerais, Brazil.
Dr. Nunes’ research has been supported by the American Heart Association (AHA) since 2009.
She is a professor of Human Physiology and Anatomy at the Florida Institute of Technology, where she continues to work on rewarding projects involving diabetes and hypertension, using animal models to investigate different pathways leading to vascular diseases and new treatment targets.
She has to her credit more than 20 peer-reviewed manuscripts, 6 book chapters, and an international patent regarding pharmaceutical compositions to improve vasculogenic erectile function.
“Major Topics in Type 1 Diabetes is a book that calls upon experts from around the world who communicate the most accurate scientific information in a way that will be useful for medical students as well as diabetic patients and their families.” - Dr. Kenia Nunes